Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Oncolytic Virotherapy · 2016-01 · 1
DOI: 10.2147/ov.s66083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncolytic Virotherapy, 2016-01. Verfasst von Guy R Simpson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, Targeted Cancer Therapy, Faculty of Health and Medical Sciences, University of Surrey, Guildford. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, Targeted Cancer Therapy, Faculty of Health and Medical Sciences, University of Surrey, Guildford.
- Targeted Therapy, The Institute of Cancer Research/The Royal Marsden NIHR Biomedical Research Centre, London.
- Targeted and Biological Therapies, Oncology and Clinical Research, Leeds Institute of Cancer and Pathology, Faculty of Medicine and Health, University of Leeds, Leeds, UK.
Zitieren
APA
Simpson, G. R., Relph, K., Harrington, K., Melcher, A., & Pandha, H. (2016). Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic Virotherapy, 1. https://doi.org/10.2147/ov.s66083
Vancouver
Simpson GR, Relph K, Harrington K, Melcher A, Pandha H. Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic Virotherapy. 2016:1. doi:10.2147/ov.s66083
BibTeX
@article{Simpson2016,
author = {Simpson, Guy R and Relph, Kate and Harrington, Kevin and Melcher, Alan and Pandha, Hardev},
title = {Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances},
journal = {Oncolytic Virotherapy},
year = {2016},
pages = {1},
doi = {10.2147/ov.s66083}
}
EUVIMED